• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病后的长期心血管结局和死亡率:一项系统评价和荟萃分析。

Long-term cardiovascular outcomes and mortality following Kawasaki disease: A systematic review and meta-analysis.

作者信息

Lao Francis, Robinson Cal H, Borovsky Dorota, Ewusie Joycelyne, Beattie Karen, Batthish Michelle

机构信息

Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

出版信息

Paediatr Child Health. 2025 Mar 27;30(5):406-413. doi: 10.1093/pch/pxaf003. eCollection 2025 Aug.

DOI:10.1093/pch/pxaf003
PMID:40917273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408477/
Abstract

OBJECTIVES

To determine if children with Kawasaki disease (KD) are at an increased long-term risk of cardiovascular disease and mortality.

METHODS

A systematic review and meta-analysis was performed. A systematic search of MEDLINE, EMBASE, CINAHL, Cochrane, and Web of Science databases was performed through 2022. English-language publications, patients 0 to 18 years at KD diagnosis, minimum follow-up >1 year, and ≥10 patients included. Of 5072 articles, 181 were included. Cardiovascular events and mortality were extracted and pooled for analysis. Meta-analyses and meta-regression analyses were performed. The primary outcome of interest was the incidence of specific cardiovascular events (composite of myocardial infarction, heart failure or cardiac arrest) and all-cause mortality. Secondary outcomes included the incidence of occlusive coronary events, myocardial infarction, heart failure, cardiac arrest, non-coronary artery bypass grafting (CABG) coronary revascularization procedures, and CABG.

RESULTS

Cardiovascular events occurred in 0.85% of children during study follow-up. The incidence rate of cardiovascular events was 370 per 100,000 person-years. Mortality occurred in 0.24% of children during study follow-up. The incidence rate of mortality was 117 per 100,000 person-years.

CONCLUSIONS

There is a low incidence of cardiovascular events and mortality following childhood KD diagnosis. Further studies are needed to better define this long-term risk.

摘要

目的

确定川崎病(KD)患儿是否存在心血管疾病和死亡的长期风险增加情况。

方法

进行了一项系统评价和荟萃分析。通过检索MEDLINE、EMBASE、CINAHL、Cochrane和Web of Science数据库,对截至2022年的文献进行了系统检索。纳入英文出版物,KD诊断时年龄为0至18岁、最短随访时间>1年且≥10例患者的研究。在5072篇文章中,纳入了181篇。提取并汇总心血管事件和死亡率进行分析。进行了荟萃分析和荟萃回归分析。主要关注的结局是特定心血管事件(心肌梗死、心力衰竭或心脏骤停的综合)和全因死亡率的发生率。次要结局包括闭塞性冠状动脉事件、心肌梗死、心力衰竭、心脏骤停、非冠状动脉旁路移植术(CABG)冠状动脉血运重建术以及CABG的发生率。

结果

在研究随访期间,0.85%的儿童发生了心血管事件。心血管事件的发生率为每10万人年370例。在研究随访期间,0.24%的儿童死亡。死亡率的发生率为每10万人年117例。

结论

儿童KD诊断后心血管事件和死亡率的发生率较低。需要进一步研究以更好地明确这种长期风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1239/12408477/9fcdf5b331a9/pxaf003_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1239/12408477/31769cf49623/pxaf003_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1239/12408477/9fcdf5b331a9/pxaf003_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1239/12408477/31769cf49623/pxaf003_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1239/12408477/9fcdf5b331a9/pxaf003_fig2.jpg

相似文献

1
Long-term cardiovascular outcomes and mortality following Kawasaki disease: A systematic review and meta-analysis.川崎病后的长期心血管结局和死亡率:一项系统评价和荟萃分析。
Paediatr Child Health. 2025 Mar 27;30(5):406-413. doi: 10.1093/pch/pxaf003. eCollection 2025 Aug.
2
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
3
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
4
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
5
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
6
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
7
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
8
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
10
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.

本文引用的文献

1
Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study.川崎病患儿的心血管结局:一项基于人群的队列研究。
Pediatr Res. 2023 Apr;93(5):1267-1275. doi: 10.1038/s41390-022-02391-3. Epub 2022 Nov 15.
2
The Long-term Cardiac and Noncardiac Prognosis of Kawasaki Disease: A Systematic Review.川崎病的长期心脏和非心脏预后:一项系统评价
Pediatrics. 2022 Mar 1;149(3). doi: 10.1542/peds.2021-052567.
3
Incidence and short-term outcomes of Kawasaki disease.川崎病的发病率及短期预后
Pediatr Res. 2021 Sep;90(3):670-677. doi: 10.1038/s41390-021-01496-5. Epub 2021 Mar 30.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey.日本川崎病确诊或漏诊病史后成人急性冠状动脉综合征的出现与特征:一项日本全国性调查
Front Pediatr. 2019 Jul 9;7:275. doi: 10.3389/fped.2019.00275. eCollection 2019.
6
Paediatric overdiagnosis modelled by coronary abnormality trends in Kawasaki disease.川崎病冠状动脉异常趋势提示儿科过度诊断。
Arch Dis Child. 2018 Oct;103(10):937-941. doi: 10.1136/archdischild-2017-313694. Epub 2018 Feb 22.
7
Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review.2004 年至 2014 年加拿大川崎病的流行病学:利用行政数据监测与定期病历回顾的比较。
Can J Cardiol. 2018 Mar;34(3):303-309. doi: 10.1016/j.cjca.2017.12.009. Epub 2017 Dec 15.
8
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
9
Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood.成人急性心肌缺血继发于儿童期漏诊的川崎病。
Am J Cardiol. 2015 Feb 15;115(4):423-7. doi: 10.1016/j.amjcard.2014.11.024. Epub 2014 Nov 29.
10
Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009.日本川崎病病史患者的死亡率:2009 年底的结果。
J Epidemiol. 2013;23(6):429-34. doi: 10.2188/jea.je20130048. Epub 2013 Sep 14.